William Robert Patterson

Title: William Robert Patterson: Revolutionizing Vascular Treatment with Filamentary Devices

Introduction:

In the world of medical inventions, William Robert Patterson from Irvine, CA stands out as a prolific inventor. With an impressive collection of 45 patents, Patterson has made significant contributions to the field of vascular treatment. His latest patents focus on the development of filamentary devices for the treatment of vascular defects. Let's delve into Patterson's innovative work and the companies he has been associated with.

Devices for Treatment of Vascular Defects:

Patterson's recent patents highlight his expertise in the development of devices and methods for treating a patient's vasculature. Specifically, he has explored the concept of permeable implants that can be delivered within a catheter lumen. These implants have a radially constrained state for insertion and an expanded state for effective treatment. The implants consist of numerous elongate filaments woven together, allowing flexibility and permeability.

One unique feature of these devices is the inclusion of a stiffer proximal portion designed to sit at the neck of an aneurysm. To enhance its rigidity, Patterson's innovations incorporate coils, stiffening elements, or reinforcement elements that are woven together with the filaments. This stiffer proximal portion provides additional stability during treatment, ensuring effective aneurysm management.

Collaborations and Companies:

Throughout his career, Patterson has collaborated with notable individuals in the medical device industry. Two of his coworkers, Todd Hewitt and Jeffrey L. Creech, have played significant roles in the development of these filamentary devices.

Patterson's expertise has been employed by several prominent companies. He has worked with Sequent Medical, Inc., a California-based medical technology company dedicated to developing innovative solutions for the treatment of neurovascular diseases. Additionally, he has shared his knowledge with Covidien LP, a subsidiary of Medtronic, which focuses on medical devices across various therapeutic areas.

Conclusion:

William Robert Patterson's 45 patents in vascular treatment showcase his invaluable contributions to the medical field. His focus on filamentary devices and their utilization in the treatment of vascular defects demonstrates his dedication to improving patient care. Patterson's collaborations with companies like Sequent Medical, Inc. and Covidien LP have solidified his position as an esteemed inventor driving innovation in the medical device industry.